Conceptio
›
Archive
›
HAL (France)
HAL (France)
open access
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial
Jacobus Pfisterer et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
A dynamic leaf gas-exchange strategy is conserved in woody plants under changing ambient CO<sub>2</sub>: evidence from carbon isotope discrimination in paleo and CO<sub>2</sub> enrichment studies
#1053610
Fine-scale genetic structure and diversity in native and introduced Arctic charr populations
#1053611
Reconfiguring Product Designer Competencies in the Age of Artificial Intelligence: Towards a Pedagogy of Mediation in Project Workshops
#1053612
Que sait-on des risques sanitaires et environnementaux des micro et nanoplastiques ?
#1053613
Gagny (Ile-de-france, Seine-Saint-Denis) 9, avenue Fournier. Rapport de diagnostic archéologique, 2024
#1053614
Record
· ID 677111
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.